Gelteq Limited (GELS)Healthcare | Drug Manufacturers - Specialty & Generic | Clayton, Australia | NasdaqCM
0.56 USD
-0.01
(-2.561%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.52 -0.03 (-0.035%) ⇩ (Aug. 28, 2026, 6:52 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:58 a.m. EDT
The immediate catalyst driving attention is a surge in trading volume and preclinical data showing improved cannabinoid absorption, which has pushed the share price higher recently. However, this momentum is dangerously disconnected from the company's financial reality. The business is hemorrhaging cash, with operating and free cash flows deeply negative, while the balance sheet is crumbling under a debt load that dwarfs its cash reserves, resulting in a precarious current ratio well below 1.0. Fundamentally, the company is generating losses and burning through equity, evidenced by negative returns on both assets and shareholders' equity. There is no dividend to provide a floor, and the lack of a multi-year price history prevents any assessment of long-term structural trends, leaving the investment thesis entirely dependent on speculative future milestones rather than current operational viability. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.138242 |
| AutoETS | 0.652568 |
| AutoTheta | 0.670663 |
| MSTL | 0.739075 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 0.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.015 |
| Excess Kurtosis | 1.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 36.01 |
| Revenue per Share | 0.046 |
| Market Cap | 5,949,993 |
| Website | https://www.gelteq.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.525 |
| Address1 | Monash Innovation Labs |
| Address2 | G.60, 22 Alliance Lane |
| All Time High | 5.5 |
| All Time Low | 0.387 |
| Ask | 0.7411 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 22,750 |
| Average Daily Volume3 Month | 3,677,437 |
| Average Volume | 3,677,437 |
| Average Volume10Days | 22,750 |
| Bid | 0.3919 |
| Bid Size | 2 |
| Book Value | 0.9026652 |
| City | Clayton |
| Country | Australia |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.5555 |
| Current Ratio | 0.091 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.575 |
| Day Low | 0.5301 |
| Debt To Equity | 36.01 |
| Display Name | Gelteq |
| Ebitda | -5,137,130 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.203 |
| Enterprise To Revenue | 23.987 |
| Enterprise Value | 11,317,147 |
| Eps Trailing Twelve Months | -0.52 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.6145 |
| Fifty Day Average Change | -0.059000015 |
| Fifty Day Average Change Percent | -0.09601305 |
| Fifty Two Week Change Percent | -52.499996 |
| Fifty Two Week High | 2.02 |
| Fifty Two Week High Change | -1.4645 |
| Fifty Two Week High Change Percent | -0.72499996 |
| Fifty Two Week Low | 0.387 |
| Fifty Two Week Low Change | 0.16849998 |
| Fifty Two Week Low Change Percent | 0.43540046 |
| Fifty Two Week Range | 0.387 - 2.02 |
| Financial Currency | AUD |
| First Trade Date Milliseconds | 1,730,208,600,000 |
| Float Shares | 5,150,874 |
| Free Cashflow | -4,751,912 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 7 |
| Fullday Change | -0.0146 |
| Fullday Change Percent | -2.56096 |
| Fullday Price | 0.5205 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.75541 |
| Gross Profits | 356,402 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.47527 |
| Held Percent Institutions | 0.0102699995 |
| Implied Shares Outstanding | 10,711,059 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,024-10-29 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Long Business Summary | Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia. |
| Long Name | Gelteq Limited |
| Market | us_market |
| Market Cap | 5,949,993 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1779819906 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -7,083,198 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 6,106,374 |
| Open | 0.5701 |
| Operating Cashflow | -3,009,640 |
| Operating Margins | -19.852829 |
| Payout Ratio | 0.0 |
| Phone | 61 3 9087 3990 |
| Post Market Change | -0.034999967 |
| Post Market Change Percent | -6.3006244 |
| Post Market Price | 0.5205 |
| Post Market Time | 1,787,957,550 |
| Previous Close | 0.5701 |
| Price Hint | 4 |
| Price To Book | 0.6153998 |
| Price To Sales Trailing12 Months | 12.611288 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.072 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0146000385 |
| Regular Market Change Percent | -2.5609608 |
| Regular Market Day High | 0.575 |
| Regular Market Day Low | 0.5301 |
| Regular Market Day Range | 0.5301 - 0.575 |
| Regular Market Open | 0.5701 |
| Regular Market Previous Close | 0.5701 |
| Regular Market Price | 0.5555 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 11,404 |
| Return On Assets | -0.17613001 |
| Return On Equity | -0.42933998 |
| Revenue Growth | 0.489 |
| Revenue Per Share | 0.046 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 10,711,059 |
| Shares Percent Shares Out | 0.0011999999 |
| Shares Short | 12,658 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 112,420 |
| Short Name | Gelteq Limited |
| Short Percent Of Float | 0.0018000001 |
| Short Ratio | 0.12 |
| Source Interval | 15 |
| State | VIC |
| Symbol | GELS |
| Total Cash | 9,349 |
| Total Cash Per Share | 0.001 |
| Total Debt | 5,113,954 |
| Total Revenue | 471,799 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.52 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.7494 |
| Two Hundred Day Average Change | -0.19390005 |
| Two Hundred Day Average Change Percent | -0.2587404 |
| Type Disp | Equity |
| Volume | 11,404 |
| Website | https://www.gelteq.com |
| Zip | 3,800 |